Please login to the form below

Not currently logged in
Email:
Password:

suspension

This page shows the latest suspension news and features for those working in and with pharma, biotech and healthcare.

Vernalis accepts £33m takeover offer from Ligand Pharma

Vernalis accepts £33m takeover offer from Ligand Pharma

of cough and cold product Tuzistra XR (codeine polistirex and chlorpheniramine polistirex suspension) – which has underperformed – and antibiotic Moxatag (amoxicillin).

Latest news

More from news
Approximately 3 fully matching, plus 133 partially matching documents found.

Latest Intelligence

  • Significant figures Significant figures

    ALIS (Amikacin liposome inhalation suspension) is being developed as a treatment for refractory non tuberculous Mycobacterial (NTM) lung disease, a rare progressive, destructive infection caused by mycobacterium avium complex.

  • Gene therapy Gene therapy

    GalNAc technology does hold potential, but has limited utility, and a recent trial suspension using this technology has not yet been fully resolved.

  • Deal Watch July 2016 Deal Watch July 2016

    Other deals where the licensee has committed real upfront money include Takeda's $28m upfront payment for ex-US rights to TiGenix's Cx601, a suspension of allogeneic adipose-derived stem

  • Oral biologics delivery still elusive Oral biologics delivery still elusive

    The Octreolin formulation is based on Chiasma's Transient Permeability Enhancer (TPE) system which combines excipients to form an oily suspension of solid hydrophilic particles in a hydrophobic medium, which protects

  • Pharma deals in August 2015 Pharma deals in August 2015

    Collaboration. 219. Relypsa. Vifor Fresenius. Patiromer oral suspension in treating hyperkalemia.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics